SHORT- VERSUS LONG-COURSE RADIATION IN TOTAL NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RECTAL CANCER: A PROPENSITY-MATCHED NATIONAL CANCER DATABASE ANALYSIS

BACKGROUND: Locally advanced rectal cancer is treated with total neoadjuvant therapy which consists of neoadjuvant chemotherapy, radiation, and surgery. The comparative efficacy of long and short course radiotherapy within total neoadjuvant therapy remains uncertain. OBJECTIVE: Compare overall survival and pathological outcomes between patients treated with long or short course radiation as components of total neoadjuvant therapy. DESIGN: Retrospective cohort study. SETTINGS: National Cancer Database, 2018 to 2023. PATIENTS: Adults with clinical Stage II or III rectal adenocarcinoma treated with neoadjuvant chemotherapy and radiation followed by radical surgical resection. MAIN OUTCOME MEASURES: Overall survival and pathological outcomes in a propensity score matched cohort comparing long and short course radiation. RESULTS: A total of 12,462 patients met inclusion criteria; 10,740 (86.2%) received long course radiation and 1,722 (13.8%) received short course radiation. After 1:1 propensity score matching, 1,721 per group were identified. Overall survival at 48 months did not differ (log rank p = 0.397). There were no differences in pathological complete response rate, pathological tumor stage, tumor downstaging, or pathological nodal stage. The long course radiotherapy group had higher nodal downstaging (66.5 vs 62.7%, p = 0.023) and a nonsignificant trend towards lower nodal disease (N0 73.9 vs 70.7%, N1 21.5 vs 23.3%, and N2 4.6 vs 6.0%, respectively, p = 0.062). LIMITATIONS: Residual confounding from unmeasured clinical and treatment details is possible. This cohort was restricted to patients who underwent resection. CONCLUSIONS: Among locally advanced rectal cancer patients treated with total neoadjuvant therapy and radical resection, long and short course radiotherapy had similar overall survival, but long course radiotherapy patients had higher rates of nodal downstaging. These findings support the use of either long or short course radiotherapy regimens when planned resection is intended, but the clinical significance of differences in nodal downstaging remain uncertain. See Video Abstract.

Authors

Institutions

Publication Details

Journal
Diseases of the Colon & Rectum
Published
2026-08-14
DOI
https://doi.org/10.1097/dcr.0000000000004374
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SHORT- VERSUS LONG-COURSE RADIATION IN TOTAL NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RECTAL CANCER: A PROPENSITY-MATCHED NATIONAL CANCER DATABASE ANALYSIS

James J. Whitbread, Miloslawa Stem, John Migaly, Alodia Gabre-Kidan et al.
Diseases of the Colon & Rectum
Colorectal Cancer Surgical Treatments
article

SHORT- VERSUS LONG-COURSE RADIATION IN TOTAL NEOADJUVANT THERAPY FOR LOCALLY ADVANCED RECTAL CANCER: A PROPENSITY-MATCHED NATIONAL CANCER DATABASE ANALYSIS

James J. Whitbread, Miloslawa Stem, John Migaly, Alodia Gabre-Kidan, Bryan Szeglin, Michael Consul, Andrea Bafford, Megan Breckheimer
article en

Abstract

BACKGROUND: Locally advanced rectal cancer is treated with total neoadjuvant therapy which consists of neoadjuvant chemotherapy, radiation, and surgery. The comparative efficacy of long and short course radiotherapy within total neoadjuvant therapy remains uncertain. OBJECTIVE: Compare overall survival and pathological outcomes between patients treated with long or short course radiation as components of total neoadjuvant therapy. DESIGN: Retrospective cohort study. SETTINGS: National Cancer Database, 2018 to 2023. PATIENTS: Adults with clinical Stage II or III rectal adenocarcinoma treated with neoadjuvant chemotherapy and radiation followed by radical surgical resection. MAIN OUTCOME MEASURES: Overall survival and pathological outcomes in a propensity score matched cohort comparing long and short course radiation. RESULTS: A total of 12,462 patients met inclusion criteria; 10,740 (86.2%) received long course radiation and 1,722 (13.8%) received short course radiation. After 1:1 propensity score matching, 1,721 per group were identified. Overall survival at 48 months did not differ (log rank p = 0.397). There were no differences in pathological complete response rate, pathological tumor stage, tumor downstaging, or pathological nodal stage. The long course radiotherapy group had higher nodal downstaging (66.5 vs 62.7%, p = 0.023) and a nonsignificant trend towards lower nodal disease (N0 73.9 vs 70.7%, N1 21.5 vs 23.3%, and N2 4.6 vs 6.0%, respectively, p = 0.062). LIMITATIONS: Residual confounding from unmeasured clinical and treatment details is possible. This cohort was restricted to patients who underwent resection. CONCLUSIONS: Among locally advanced rectal cancer patients treated with total neoadjuvant therapy and radical resection, long and short course radiotherapy had similar overall survival, but long course radiotherapy patients had higher rates of nodal downstaging. These findings support the use of either long or short course radiotherapy regimens when planned resection is intended, but the clinical significance of differences in nodal downstaging remain uncertain. See Video Abstract.

Diseases of the Colon & Rectum
Johns Hopkins University (US), Johns Hopkins Medicine (US)
Openalex Percentile: Top 12%
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.